The goals of treatment are to decrease the frequency of angina, increase longevity, and improve patients' QOL. Management of risk factors is an essential component of this therapy. Also important is ...

In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug, ...

Advances in pharmacotherapy for stable angina have produced a wide choice of drugs with various mechanisms of action, potentially enabling individualized, patient-specific treatment strategies to be ...

BECAUSE angina pectoris is a consequence of inadequate myocardial oxygenation, ideal therapy for this incapacitating symptom would be directed toward both increasing coronary blood flow and decreasing ...

Individuals with undetected stable angina pectoris (SAP) as a consequence of undiagnosed coronary artery disease are at high risk of poor quality of life and a premature fatal event (for example, ...

Angina pectoris, often shortened to angina, is chest pain or discomfort caused by reduced blood flow to the heart and most commonly—but not always—a symptom of coronary artery disease (CAD). The term ...

Stable angina can be treated with rest or nitrate medications; however, unstable angina is a medical emergency as it can lead to a heart attack. — 123rf Angina pectoris, often shortened to angina, is ...

IN our inquiries into any particular subject of Medicine, our labours will generally be shortened and directed to their proper objects, by a knowledge of preceding discoveries. When Dr. Heberden, in ...

Angina, a type of chest pain, can be stable or unstable. Stable angina follows a predictable pattern. For example, it may occur regularly after strenuous exercise and go away shortly. Angina is a type ...

When a robust man suddenly drops dead and the newspapers report “heart failure,” the probability is that he died during an attack of angina pectoris. If he had gone to his doctor the day before, the ...

The global angina pectoris drugs market is poised for substantial growth over the next decade, driven by a combination of rising cardiovascular disease incidence, advances in drug delivery ...

Background: There is speculation that women and South Asian people are more likely than men and white people to report atypical angina and that they are less likely to undergo invasive management of ...